Work

668 Response to taxane chemotherapy as first subsequent therapy after abiraterone acetate in patients with metastatic castration-resistant prostate cancer (mCRPC): Post hoc analysis of COU-AA-302

Year: 2015

Type: conference-abstract

Source: European Urology Supplements

DOI: 10.1016/s1569-9056(15)60661-3

Authors: F. Saad, J.S. De Bono, M.R. Smith, D.E. Rathkopf, P.F.A. Mulders, E.J. Small, N.D. Shore, K. Fizazi, P. De Porre, T. Kheoh, J. Li, M.B. Todd, T.W. Griffin, C.J. Ryan

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2317437411

Cites:

Cited by: 1

Related to: 10